-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$15.001090.48% Upside
Enlivex Therapeutics Ltd. Frequently Asked Questions
-
What analysts cover Enlivex Therapeutics Ltd.?
Enlivex Therapeutics Ltd. has been rated by research analysts at H.C. Wainwright in the past 90 days.